Valneva SE (VALN) stock
Close on Nov 17, 2026Market cap $482.87MP/E –Yield –
Earnings
Valneva's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Valneva's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | Mar 18, 2026during market hours | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025during market hours | €49.20M | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 20, 2025before the open | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 15, 2024before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 16, 2023before the open | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022after the close | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 4, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Valneva's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total revenues | FY2025 | 180 – 190 | 180 – 190 | Reaffirmed | May 7, 2025 |
| Product sales | FY2025 | 170 – 180 | 170 – 180 | Raised | May 7, 2025 |
| Total R&D investments | FY2025 | 90 – 100 | 90 – 100 | Lowered | May 7, 2025 |
| Total revenues | FY2026 | 155 – 170 | – | New | Mar 18, 2026 |
| product sales | FY2026 | 145 – 160 | – | New | Mar 18, 2026 |
Guidance history
Every forecast Valneva put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Mar 18, 2026 | product sales | FY2026 | 145 – 160 | New |
| Mar 18, 2026 | Total revenues | FY2026 | 155 – 170 | New |
| May 7, 2025 | Product sales | FY2025 | 170 – 180 | Raised |
| May 7, 2025 | Total R&D investments | FY2025 | 90 – 100 | Lowered |
| May 7, 2025 | Total revenues | FY2025 | 180 – 190 | Reaffirmed |
| Mar 20, 2025 | Product sales | FY2025 | 170 – 180 | New |
| Mar 20, 2025 | Total R&D investments | FY2025 | 90 – 100 | Lowered |
| Mar 20, 2025 | Total revenues | FY2025 | 180 – 190 | New |
| Feb 15, 2024 | Other income | FY2024 | 95 – 105 | New |
| Feb 15, 2024 | R&D expenses | FY2024 | 65 – 90 | Lowered |
| Feb 15, 2024 | Product sales | FY2024 | 150 – 180 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Valneva filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?